Format

Send to

Choose Destination
J Toxicol Sci. 1996 Dec;21(5):309-16.

Strategic proposals for avoiding toxic interactions with drugs for clinical use during development and after marketing of a new drug: pharmacokinetic consideration.

Author information

1
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
PMID:
9035043
DOI:
10.2131/jts.21.5_309
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center